Preexisting Heterotypic Ligand-blocking Antibody Does Not Protect Against Genogroup II Norovirus Episodes in Young Children
Supporting Files
-
7 18 2022
-
File Language:
English
Details
-
Alternative Title:J Pediatric Infect Dis Soc
-
Personal Author:
-
Description:A birth cohort design was used to understand whether heterotypic ligand-blocking norovirus antibodies provide cross-protection within the GII genogroup. We found that almost one-half of children who experienced a norovirus GII episode had preexisting antibodies heterotypic to the infecting genotype; therefore, these antibodies did not provide cross-protection.
-
Subjects:
-
Keywords:
-
Source:J Pediatric Infect Dis Soc. 11(10):459-462
-
Pubmed ID:35849117
-
Pubmed Central ID:PMC9595053
-
Document Type:
-
Funding:
-
Volume:11
-
Issue:10
-
Collection(s):
-
Main Document Checksum:urn:sha256:b157a77129f3ebbdd9468c06778410790a3ad784c30499550b3edb33356e0eef
-
Download URL:
-
File Type:
Supporting Files
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access